Dr. Ronald Swerdloff’s research includes basic investigations, clinical trials, and translational studies bridging the two branches – basic (bench) and translational (clinical) – of biomedical science. Dr. Swerdloff is particularly known for his research on male reproductive biology and androgen drug development.
- M.D., 1962, University of California, San Francisco
- Residency, 1966-1967, Medicine, University of California, Los Angeles
- Residency, 1962-1964, Medicine, University of Washington, Seattle
- Chief, Division of Endocrinology, Associate Chair of the Department of Medicine, Harbor-UCLA Medical Center
- Professor of Medicine, David Geffen School of Medicine at Harbor-UCLA Medical Center
- Senior Scientist, LA BioMed
AWARDS & RECOGNITIONS
- Sherman Mellinkoff Award as the most distinguished faculty member at UCLA School of Medicine
- Endocrine Society’s Distinguished Educator Award
- American Association of Andrology’s Distinguished Andrologist Award
- Elected Master of the American College of Physicians
Recent and/or Significant Studies:
Genetic and hormonal control of bone volume, architecture, and remodeling in XXY mice. Liu PY, Kalak R, Lue Y, Jia Y, Erkkila K, Zhou H, Seibel MJ, Wang C, Swerdloff RS, Dunstan CR.
Opposing roles of insulin-like growth factor binding protein 3 and humanin in the regulation of testicular germ cell apoptosis.
Lue Y, Swerdloff R, Liu Q, Mehta H, Hikim AS, Lee KW, Jia Y, Hwang D, Cobb LJ, Cohen P, Wang C.
Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.
The Journal of clinical endocrinology and metabolism. 2008; 93(5): 1774-83.Liu Peter Y, Swerdloff Ronald S, Anawalt Bradley D, Anderson Richard A, Bremner William J, Elliesen Joerg, Gu Yi-Qun, Kersemaekers Wendy M, McLachlan Robert I, Meriggiola M Cristina, Nieschlag Eberhard, Sitruk-Ware Regine, Vogelsong Kirsten, Wang Xing-Hai, Wu Frederick C W, Zitzmann Michael, Handelsman David J, Wang Christina